Cargando…
Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma
Primary hyperparathyroidism is the first differential diagnosis when a patient presents with asymptomatic hypercalcemia. The symptoms of hyperparathyroidism can be as grave as skeletal, cardiovascular, and neuropsychological changes. Skeletal manifestations are relatively common, and patient may pre...
Autores principales: | Das, Kalpa Jyoti, Sehgal, Aditi Khurana, Jaiman, Ashish, Sethi, Ravinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479919/ https://www.ncbi.nlm.nih.gov/pubmed/26170573 http://dx.doi.org/10.4103/0972-3919.158541 |
Ejemplares similares
-
Ectopic Parathyroid Incidentaloma on Tc99m SestaMIBI Myocardial Perfusion Imaging
por: Hussain, Rola Aatif Hasan, et al.
Publicado: (2017) -
Reverse perfusion pattern in myocardial spect with 99mTc-SestaMIBI
por: Schillaci, O, et al.
Publicado: (2013) -
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019) -
Protocol for a MULTI-centre feasibility study to assess the use of (99m)Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)
por: Warren, Hannah, et al.
Publicado: (2023) -
The Use of (99m)Tc-Methoxy-isobutyl-isonitrile (sestaMIBI) Uptake on Scintigraphy ((99m)-STS) in Amiodarone-Induced Thyrotoxicosis: Case Series and Review of the Literature
por: Elshimy, Ghada, et al.
Publicado: (2020)